GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets
B. Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets
C. Glimepiride 2mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets
D. Glimepiride 2mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.3mg Tablets
E. Glimepiride 2mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.3mg Tablets

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets
Each uncoated Bilayered tablet contains:
Glimepiride IP…………………………………..1mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Voglibose IP………………………………………0.2mg
Excipients………………………………………q.s
Colour: Lake Quinoline Yellow

B) Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets
Each uncoated Bilayered tablet contains:
Glimepiride IP…………………………………..1mg
Metformin Hydrochloride IP…………….1000mg
(As Sustained Release Form)
Voglibose IP………………………………………0.2mg
Excipients………………………………………q.s
Colour: Sunset Yellow FCF


C) Glimepiride 2mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.2mg Tablets
Each uncoated Bilayered tablet contains:
Glimepiride IP…………………………………..2mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Voglibose IP………………………………………0.2mg
Excipients………………………………………q.s
Colour: Indigo Carmine

D) Glimepiride 2mg + Metformin Hydrochloride 500mg (SR) + Voglibose 0.3mg Tablets
Each uncoated Bilayered tablet contains:
Glimepiride IP…………………………………..2mg
Metformin Hydrochloride IP…………….500mg
(As Sustained Release Form)
Voglibose IP………………………………………0.3mg
Excipients………………………………………q.s
Colour: Ponceau 4R

E) Glimepiride 2mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.3mg Tablets
Each uncoated Bilayered tablet contains:
Glimepiride IP…………………………………..2mg
Metformin Hydrochloride IP…………….1000mg
(As Sustained Release Form)
Voglibose IP………………………………………0.3mg
Excipients………………………………………q.s
Colour: Red Oxide Of Iron

THERAPEUTIC INDICATIONS:

GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.

Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets Technical Specification:

Product Name: Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets
Brand Name: Generic
Strength:  (1mg+500mg+0.2mg), (1mg+1000mg+0.2mg),    (2mg+500mg+0.2mg),     (2mg+500mg+0.3mg),    (2mg+1000mg+0.3mg)
Dosage Form: Tablets (uncoated)
Route of Administration: Via Oral Route
Packing: 10 strips of 15 tablets each
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antidiabetic
Indication: GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.
Storage: Store at temperature not exceeding 30℃. Store in cool, dry & dark place. Protect from Light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets

 QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets
    Each uncoated Bilayered tablet contains:
    Glimepiride IP…………………………………..1mg
    Metformin Hydrochloride IP………………….1000mg
    (As Sustained Release Form)
    Voglibose IP………………………………….0.2mg
    Excipients………………………………………q.s
    Colour: Sunset Yellow FCF

THERAPEUTIC INDICATIONS:

GLIMEPIRIDE+METFORMIN+VOGLIBOSE is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose.

CAUTION & SCHEDULE:

CAUTION:  Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

CAUTION: It is dangerous to take the prescription except under medical supervision.

SCHEDULE H PRESCRIPTION DRUG-WARNING: To be sold by retail on the prescription of a registered medical practitioner only. 

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction – Understanding Glimepiride + Metformin (SR) + Voglibose Tablets and Global Demand

What Are These Tablets?

Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets are an advanced oral antidiabetic formulation that helps:

  • Improve insulin secretion

  • Increase glucose utilization

  • Reduce hepatic glucose production

  • Control post-prandial sugar spikes

This triple combination is often prescribed to patients whose blood sugar is not controlled by Metformin alone or dual therapy.

Uses

This medicine is used for:

  • Management of Type 2 Diabetes Mellitus

  • Reducing fasting and post-meal glucose levels

  • Enhancing long-term glycemic control

  • Preventing diabetes-related complications

Taj Pharma assures high purity, consistent potency, and global-standard manufacturing for all batches.

Why Global Demand Is Rising

The demand for Glimepiride + Metformin SR + Voglibose Tablets export from India is growing due to:

  • Rising diabetes burden in developing nations

  • Affordable Indian generic formulations

  • WHO-GMP and international regulatory acceptance

  • Increasing government and private tenders


 Detailed Insights for Importers, Exporters & Pharmaceutical Buyers

Taj Pharma offers comprehensive regulatory and commercial support, making it the top choice for global procurement.


 1. Complete Regulatory Documentation Support

Buyers receive:

  • WHO-GMP Certificate

  • EU-GMP / PIC/s compliance (where applicable)

  • Certificate of Analysis (COA)

  • Certificate of Pharmaceutical Product (COPP)

  • Stability Data Zone II & IVB

  • Master Formula Record (MFR)

  • Batch Manufacturing Record (BMR)

  • DMF / CTD Dossier (ready-to-file)

  • Bioequivalence (BE) data (on request)

Taj Pharma maintains full transparency and adheres strictly to global regulatory norms.


 2. Custom Packaging, Private Labelling & Export-Friendly Design

Customisation options include:

  • Blister or Alu-Alu packing

  • Bulk packing for institutional tenders

  • Bottle packing (HDPE / PET)

  • Multilingual pack inserts

  • Customized branding for distributors

  • Market-specific artwork options


 3. Shelf-Life, Storage & Dosage Form

  • Shelf-life: 24–36 months

  • Dosage Form: Film-coated tablets, Sustained Release

  • Storage: Store below 30°C, protected from moisture

  • Packaging: 10×10, 10×15, 10×1 blister strips


  4. Export Certifications Ensuring Global Acceptance

Taj Pharma offers:

  • WHO-GMP manufacturing standards

  • ISO 9001:2015 certification

  • cGMP, GLP compliant units

  • COPP for multiple countries

  • CTD / ACTD dossiers

  • GMP audit readiness for MOH tenders


  5. Target Export Markets

Taj Pharma exports widely to:

Asia: Philippines, Vietnam, Afghanistan, Cambodia, Sri Lanka, Nepal
Africa: Kenya, Uganda, Rwanda, Nigeria, Ethiopia, Ghana
Middle East: Iraq, Yemen, UAE, Saudi Arabia
CIS: Kazakhstan, Uzbekistan, Tajikistan
Latin America: Peru, Ecuador, Bolivia


 Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter Globally

Taj Pharma stands apart as the 1 Glimepiride + Metformin + Voglibose Tablets manufacturer in India due to unmatched quality, reliability, and scale.


 1. State-of-the-Art WHO-GMP & EU-GMP Manufacturing

Located in Vapi, Gujarat, Taj Pharma’s world-class manufacturing plant offers:

  • Automated granulation and compression systems

  • Zero-contamination production zones

  • High-precision QC testing (HPLC, GC, UV)

  • Dedicated R&D and formulation development lab


 2. Strict Quality Assurance & Affordable Pricing

Taj Pharma ensures:

  • Batch-to-batch consistency

  • High dissolution and bioavailability

  • Impurity profiling

  • Regulatory-compliant packaging

The company offers the best export pricing due to large-scale production and optimized supply chains.


 3. Robust Global Supply Chain & Fast Dispatch

Export buyers benefit from:

  • Fast shipment scheduling

  • Dedicated export documentation team

  • Support for seaport & airport clearance

  • Multimodal shipping options


 Top 20 Countries  

India | Vietnam | UAE | Saudi Arabia | Kenya | Tanzania | Nigeria | Philippines | Cambodia | Ghana | Peru | Colombia | Uzbekistan | Kazakhstan | Sri Lanka | Myanmar | Yemen | Oman | South Africa | Chile


 Technical Product Specification Table

Parameter Details
Product Name Glimepiride + Metformin SR + Voglibose Tablets
Strength 1mg + 1000mg (SR) + 0.2mg
Manufacturer Taj Pharma India
Dosage Form Film-coated tablet
Therapeutic Class Antidiabetic
Packaging Blister / Alu-Alu / Bottle
Shelf-Life 24–36 months
Storage < 30°C, dry place
Certifications WHO-GMP, ISO, COPP, CTD
Indication Type 2 Diabetes Mellitus
Market Availability PAN India & Global Export

 Call to Action  

Looking for a reliable Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets manufacturer and supplier in India?

Taj Pharma guarantees:

  • Competitive pricing

  • Premium quality

  • Global regulatory support

  • Fast export delivery

📩 Contact Taj Pharma for quotations, samples, and documentation.
🌐 www.tajpharma.com


 Top 20 FAQs  

1. What are these tablets used for?

They are used for treating Type 2 Diabetes Mellitus.

2. Who manufactures them in India?

Taj Pharma is one of the largest manufacturers.

3. Are these tablets WHO-GMP certified?

Yes, Taj Pharma manufactures under WHO-GMP standards.

4. Can importers get COPP certificates?

Yes, COPP is provided for eligible markets.

5. Is private labelling available?

Yes, Taj Pharma provides customized branding.

6. Do these tablets cause hypoglycemia?

Yes, especially if meals are skipped or combined with other antidiabetics.

7. Should they be taken with food?

Yes, to avoid gastric discomfort.

8. What are common side effects?

Nausea, constipation, abdominal pain, low blood sugar.

9. Can wholesalers export these tablets?

Yes, Taj Pharma is a top exporter.

10. Are dossiers available?

CTD dossiers are provided.

11. What is the shelf-life?

24–36 months.

12. Which packaging options are available?

Blister, Alu-Alu, bottle, or bulk.

13. Are stability studies provided?

Yes, Zone II & IVB.

14. What is the HS Code?

HS Code: 300490.

15. Can I get tender pricing?

Yes, Taj Pharma supports tender participation.

16. Are BE studies available?

On request.

17. What is MOQ for export?

Varies by country; Taj Pharma offers flexible MOQs.

18. Which countries import these tablets?

Asia, Africa, Middle East, CIS & Latin America.

19. Are samples available?

Yes, quality samples are provided.

20. How to place an order?

Through email, website inquiry, or phone.

With world-class manufacturing, strict quality standards, competitive pricing, and unmatched export expertise, Taj Pharma stands as the leading manufacturer, supplier, and exporter of Glimepiride 1mg + Metformin Hydrochloride 1000mg (SR) + Voglibose 0.2mg Tablets in India.